EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-virulence potential of iclaprim, a novel folic acid synthesis inhibitor, against Staphylococcus aureus

Lingyun Hao, Jingwen Zhou, Han Yang, Chunyan He, Wen Shu, Haoyue Song, Qingzhong Liu

Applied Microbiology and Biotechnology · 2024

DOI: 10.1007/s00253-024-13268-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, 2024. Verfasst von Lingyun Hao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Staphylococcus aureus, Biofilms, Virulence Factors, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation, Science and Technology Commission of Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infections caused by Staphylococcus aureus pose a significant global public problem. Therefore, new antibiotics and therapeutic strategies are needed to combat this pathogen. This investigation delves into the effects of iclaprim, a newly discovered inhibitor of folic acid synthesis, on S . aureus virulence. The phenotypic and genotypic effects of iclaprim were thoroughly examined in relation to virulence factors, biofilm formation, and dispersal, as well as partial virulence-encoding genes associated with exoproteins, adherence, and regulation in S . aureus MW2, N315, and ATCC 25923. Then, the in vivo effectiveness of iclaprim on S . aureus pathogenicity was explored by a Galleria mellonella larvae infection model. The use of iclaprim at sub-inhibitory concentrations (sub-MICs) resulted in a reduction of α-hemolysin (Hla) production and a differential effect on the activity of coagulase in S . aureus strains. The results of biofilm formation and eradication assay showed that iclaprim was highly effective in depolymerizing the mature biofilm of S . aureus strains at concentrations of 1 MIC or greater, however, inhibited the biofilm-forming ability of only strains N315 and ATCC 25923 at sub-MICs. Interestingly, treatment of strains with sub-MICs of iclaprim resulted in significant stimulation or suppression of most virulence-encoding genes expression. Iclaprim did not affect the production of δ-hemolysin or staphylococcal protein A (SpA), nor did it impact the total activity of proteases, nucleases, and lipases. In vivo testing showed that sub-MICs of iclaprim significantly improves infected larvae survival. The present study offered valuable insights towards a better understating of the influence of iclaprim on different strains of S. aureus . The findings suggest that iclaprim may have potential as an anti-virulence and antibiofilm agent, thus potentially mitigating the pathogenicity of S . aureus and improving clinical outcomes associated with infections caused by this pathogen. Key points • Iclaprim effectively inhibits α-hemolysin production and biofilm formation in a strain-dependent manner and was an excellent depolymerizing agent of mature biofilm • Iclaprim affected the mRNA expression of virulence-encoding genes associated with exoproteins, adherence, and regulation • In vivo study in G. mellonella larvae challenged with S. aureus exhibited that iclaprim improves larvae survival

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcus aureusBiofilmsVirulence FactorsAnti-Bacterial AgentsStaphylococcal InfectionsLarvaMicrobial Sensitivity TestsAnimalsVirulenceMothsHemolysin ProteinsFolic AcidFolic Acid AntagonistsCoagulaseDisease Models, AnimalPyrimidines

Stichwörter der Autor:innen

Staphylococcus aureusAnti-virulenceAntibiofilmIclaprimSub-inhibitory concentration

Substanzen

Virulence FactorsAnti-Bacterial AgentsiclaprimHemolysin ProteinsFolic AcidFolic Acid AntagonistsCoagulasePyrimidines

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Department of Clinical Laboratory, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 274 Zhijiang Middle Rd., Shanghai, 200071, China.
  • Department of Clinical Laboratory, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 274 Zhijiang Middle Rd., Shanghai, 200071, China. jiaodamedicine@foxma…

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation, Science and Technology Commission of Shanghai

Zitieren

APA

Hao, L., Zhou, J., Yang, H., He, C., Shu, W., Song, H., & Liu, Q. (2024). Anti-virulence potential of iclaprim, a novel folic acid synthesis inhibitor, against Staphylococcus aureus. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-024-13268-2

Vancouver

Hao L, Zhou J, Yang H, He C, Shu W, Song H, et al. Anti-virulence potential of iclaprim, a novel folic acid synthesis inhibitor, against Staphylococcus aureus. Applied Microbiology and Biotechnology. 2024. doi:10.1007/s00253-024-13268-2

BibTeX
@article{Hao2024,
  author = {Hao, Lingyun and Zhou, Jingwen and Yang, Han and He, Chunyan and Shu, Wen and Song, Haoyue and Liu, Qingzhong},
  title = {Anti-virulence potential of iclaprim, a novel folic acid synthesis inhibitor, against Staphylococcus aureus},
  journal = {Applied Microbiology and Biotechnology},
  year = {2024},
  doi = {10.1007/s00253-024-13268-2}
}
Kostenlos starten →